Rufloxacin hydrochloride (MF-934 hydrochloride) is a fluoroquinolone antibiotic that acts as a topoisomerase inhibitor. It has been utilized in research to study its antibacterial mechanisms and immunomodulatory effects, including the inhibition of B-cell differentiation in human mononuclear cells, in both in vitro and in vivo experimental models.